Tower Research Capital (TRC)’s CASI Pharmaceuticals CASI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-327
Closed -$837 5936
2023
Q3
$837 Buy
327
+123
+60% +$315 ﹤0.01% 5465
2023
Q2
$510 Sell
204
-1,470
-88% -$3.68K ﹤0.01% 5588
2023
Q1
$4K Sell
1,674
-1,820
-52% -$4.35K ﹤0.01% 5054
2022
Q4
$7K Buy
3,494
+1,189
+52% +$2.38K ﹤0.01% 4536
2022
Q3
$6K Buy
2,305
+248
+12% +$646 ﹤0.01% 4992
2022
Q2
$6K Buy
2,057
+1,848
+884% +$5.39K ﹤0.01% 4897
2022
Q1
$2K Sell
209
-350
-63% -$3.35K ﹤0.01% 5519
2021
Q4
$4K Sell
559
-4,851
-90% -$34.7K ﹤0.01% 5284
2021
Q3
$64K Buy
5,410
+4,975
+1,144% +$58.9K ﹤0.01% 2756
2021
Q2
$7K Sell
435
-151
-26% -$2.43K ﹤0.01% 4544
2021
Q1
$14K Sell
586
-1,229
-68% -$29.4K ﹤0.01% 4144
2020
Q4
$54K Sell
1,815
-4,466
-71% -$133K ﹤0.01% 3041
2020
Q3
$96K Buy
6,281
+5,166
+463% +$79K ﹤0.01% 3170
2020
Q2
$28K Buy
+1,115
New +$28K ﹤0.01% 3479
2020
Q1
Sell
-22
Closed -$1K 3100
2019
Q4
$1K Sell
22
-128
-85% -$5.82K ﹤0.01% 3217
2019
Q3
$5K Sell
150
-23
-13% -$767 ﹤0.01% 3291
2019
Q2
$6K Sell
173
-1,111
-87% -$38.5K ﹤0.01% 2832
2019
Q1
$37K Buy
1,284
+1,109
+634% +$32K ﹤0.01% 1918
2018
Q4
$7K Sell
175
-422
-71% -$16.9K ﹤0.01% 2670
2018
Q3
$28K Buy
+597
New +$28K ﹤0.01% 2117
2016
Q1
Sell
-60
Closed -$1K 4161
2015
Q4
$1K Buy
+60
New +$1K ﹤0.01% 4031
2015
Q3
Sell
-30
Closed -$1K 4046
2015
Q2
$1K Sell
30
-301
-91% -$10K ﹤0.01% 3963
2015
Q1
$5K Buy
331
+274
+481% +$4.14K ﹤0.01% 3224
2014
Q4
$1K Buy
+57
New +$1K ﹤0.01% 3601
2014
Q1
Sell
-476
Closed -$8K 4476
2013
Q4
$8K Buy
476
+438
+1,153% +$7.36K ﹤0.01% 3176
2013
Q3
$1K Sell
38
-1,419
-97% -$37.3K ﹤0.01% 4274
2013
Q2
$29K Buy
+1,457
New +$29K ﹤0.01% 1364